Barw Barw Medical Journal 2960-1959 2026 05 27 Clinicopathological Characteristics and Survival Outcomes of Breast Cancer in Young Women 19 26 10.58742/bmj.v4i1.231 eng Shaban Tofiq Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drone@gmail.com Lana Pshtiwan 1. Department of Radiology, Shar Teaching Hospital, Sulaymaniyah, Iraq 2. Department of Radiology, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drtwo@gmail.com Ari Abdullah 1. Department of Pathology, Sulaymaniyah Teaching Hospital, Zanko Street, Sulaymaniyah, Iraq 2. Department of Pathology, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drthree@gmail.com Sara Ahmed Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drfour@gmail.com Banu Mazin Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drfive@gmail.com Shilan Qadir Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drsix@gmail.com Vanya Jwamer Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drseven@gmail.com Harzal Fatih Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.dreight@gmail.com Masty Ahmed Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. hoshmaandasaad@gmail.com Abdullah Qadir Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. sht.drone@gmail.com Muhammad Hamasalih Department of Scientific Affairs, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. hamatofeq2002@gmail.com Hiwa Abdullah Kscien Organization for Scientific Research (Middle East Office), Hamdi Street, Sulaymaniyah (46001), Iraq. hiewaom96@gmail.com Abdulwahid Salih Department of Breast Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. A.salih@smartglobalholding.co.uk 2026 03 15 Introduction Breast cancer in young women, defined as diagnosis before 40 years of age. It is characterized by poorer outcomes compared with older patients. Regional data on the disease in the Middle Eastern population remain limited. This study focused on the clinicopathological profile of young women with breast cancer. Methods This retrospective, single-center cohort study was conducted between February 2018 and February 2025. Demographic, clinical, pathological, treatment, and follow-up data were extracted from electronic medical records. Inclusion criteria were women under 40 years diagnosed with primary breast cancer. Patients with incomplete records or without surgical treatment were excluded. Results A total of 564 patients with a median age of 36 years (IQR: 5) were included. A breast mass was the predominant chief complaint (85.5%), and 74.7% presented within 3 months. Median tumor size was 25 mm. Invasive ductal carcinoma was the predominant subtype (88%). Triple-negative breast cancer was identified in 73 patients (12.9%), of which 76.1% were Grade III (p<0.001). Negative estrogen and progesterone receptor status was significantly associated with Grade III (p<0.001). Wide local excision was performed in 67.0% of cases. Overall survival was 98.5% at 60 months. Conclusion High tumor grade was significantly associated with triple negative breast cancer, ER-negative, and PR-negative status, but not with HER2 status. Symptom duration showed no association with tumor size. Ki-67 was significantly higher in Grade III tumors, reinforcing the aggressive phenotype of breast cancer in young women